Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech. Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks? This article provides a list of Biotech stocks which have generated the highest returns in the year 2020 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Dec 31, 2020, and the top 10 return generating Biotech stocks are listed below.
Try our new Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) Novavax, Inc. (NVAX)
There's more... See price performance, YTD-gains, market-cap and other details of all the 522 Biotech stocks with sorting features in a tabular format. Alternatively, one can also explore the List of Top Biotech ETFs.
Here's a look at the basic details and how the above mentioned stocks fared during the period:
Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novavax. The Maryland, MD-headquartered company Novavax, Inc. (NVAX) is ranked number one among the best performing stocks of Biotech of 2020. The Health Care sector business falls under the Biotech Biological Products industrial sub-sector. Since the start of the year 2020, the stock price of Novavax has changed by 2701.76 percent, which is calculated based on the previous year's closing price of $3.98 per share and year-to-date closing price of $111.51 per share as of writing. The market value of the company as indicated by its market-cap changed from $105.78 million to $7.1 billion during the same period. Along with Biotech, the company is also in the business of Health Care, Biotech Biological Products, Biotech Products, Biotechnology, Healthcare, Wilshire 5000, Russell 2000, among other usual products and services. Novavax continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, Russell 2000 index, and a few other larger indexes which are part of the stock market.
Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novus Therapeutics. During the given months of the year 2020, Novus Therapeutics, Inc. (NVUS) was successful in generating YTD returns of 2555.17 percentage which helped it gain the number two spot in the list of the top performing stocks which generated maximum returns during year 2020 till date. As of December of the previous year, the stock of the Irvine, CA-based Novus Therapeutics closed at a price of $0.58 per share, while it traded at a price of $15.4 per share as of Dec 31, 2020. The company's market cap changed from $7.52 million to $22.12 million during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators.
The company is classified under the Health Care industry sector and further specialized as a Healthcare sector business.
Titan Pharmaceuticals, Inc. (Titan), incorporated on February 7, 1992, is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Companys segment ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Titan Pharma. Rank number three in the coveted list is held by Titan Pharmaceuticals, Inc. (TTNP) for being among the top performing stocks of 2020. Headquartered in California, CA, the Health Care sector company is categorized under the industrial sub-sector of Biotech Biological Products. Since the start of the year 2020, stock of Titan Pharma has so far gained 1631.58 percentage, based on the previous year's closing price of $0.19 per share and year-to-date price of $3.29 per share. During the same period, the market capitalization of the company changed from $12.22 million to $21.88 million. The stock of Titan Pharma continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, and several other broader level multi-cap market indicators.
Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Vaxart. At number four in the list of top stocks stands Vaxart, Inc. (VXRT), which saw a change in its stock price from the level of $0.35 apiece during previous year December end to the price of $5.71 per share as of Dec 31, 2020. It translates to a change of 1531.43 percentage. The USA-headquartered Health Care sector company also saw its market value change from $17.09 million to $583.58 million. The Healthcare specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, Russell 2000 index, and a handful of other multi-capitalization indexes.
Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Trillium Therapeutics. The Canada-based Health Care sector company Trillium Therapeutics Inc. (TRIL) holds the number five spot among the best performing stocks of the Biotech sector. Classified as the Major Pharmaceuticals business, the stock price of Trillium Therapeutics ended the previous year at a price of $1.03 per share while it reached the level of $14.71 apiece as of Dec 31, 2020 translating to a percentage change in stock price of 1328.16%. As of writing, the company's market-cap value stands at $1.47 billion.
ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Companys cancer immunotherapies target cancer ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of ImmunoCellular Therapeutics. ImmunoCellular Therapeutics, Ltd. (IMUC) has moved by 1266.67 percentage over the given period of 2020-YTD, helping it gain a place at number six among the top performing stocks. The Health Care sector company managed to achieve the feat as its stock price changed from $0.03 apiece to the price of $0.41 per share between the end of December of the previous year and Dec 31, 2020. The smart run of the California, CA-based Major Pharmaceuticals sector company lead to a handsome gain in its marketcap which changed from $1.43 million to $1.19 million over the same duration.
Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Genprex. The number seven spot in the list of top performing stocks of the Biotech sector is taken by Genprex, Inc. (GNPX). The company's stock price changed from $0.32 per share at the end of December of the previous year to the price of $4.15 per share as of writing. Overall, the stock managed to realized price change of 1196.88 percent during the given time period. The corresponding change in the market capitalization value of the Austin, TX-based Health Care sector company was from $6.16 million to $178.67 million. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Russell 2000 index, and a handful of other multi-capitalization indexes.
Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Aduro Biotech. Aduro Biotech (ADRO) generated percentage returns of 1137.29 percent during the 2020 year-to-date. Its returns are based on the share price which moved from $1.18 per share from the previous year-end to the price of $14.6 per share as of Dec 31, 2020. The company's value, as indicated by the market-cap figure, changed from $95.01 million to $236.61 million during the same period. The company is categorized as a Health Care speciality business with further classification in the Major Pharmaceuticals sub-category. Based in California, CA, the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, Russell 2000 index, and a few other wider multi-cap stock market indexes.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cyclacel Pharma. The New Jersey, NJ-based Cyclacel Pharmaceuticals, Inc. (CYCC) belongs to the Health Care sector and is categorized as a Major Pharmaceuticals company. The stock of Cyclacel Pharma ended the previous year at a price of $0.67 per share. As of Dec 31, 2020, the stock price has reached $7.81 apiece, which indicates a change of 1065.67 percent making the company rank among the top performing stocks of the Biotech for the year 2020 till date. At the end of the last year, company's market capitalization stood at $11.52 million. It has now changed to $37.99 million as of writing. Cyclacel Pharma continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.
Heat Biologics, Inc., incorporated on June 10, 2008, is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Heat Biologics. Based on the market-cap change from $16.22 million to $122.38 million during the given months of the year 2020 and the share price change from $0.48 per share to a price of $5.36 per share as of Dec 31, 2020, Heat Biologics, Inc. (HTBX) was successful in generating YTD returns of 1016.67 percentage. Standing at the number ten rank in the top performing list of Biotech stocks, the North Carolina, NC-based Heat Biologics is categorized as the Major Pharmaceuticals sub-sector business which falls under the larger Health Care sector. It is also a part of few famous stock indexes that are used to track the overall performance of the stock market. They include Wilshire 5000 index, and a few more broader-level indexes that are actively tracked in the market.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.